- Home
- ALDX vs PPT Comparison
ALDX vs PPT Comparison
Compare ALDX & PPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- PPT
- Stock Information
- Founded
- ALDX 2004
- PPT 1988
- Country
- ALDX United States
- PPT United States
- Employees
- ALDX N/A
- PPT N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- PPT Finance Companies
- Sector
- ALDX Health Care
- PPT Finance
- Exchange
- ALDX Nasdaq
- PPT Nasdaq
- Market Cap
- ALDX 326.6M
- PPT 351.7M
- IPO Year
- ALDX 2014
- PPT N/A
- Fundamental
- Price
- ALDX $5.81
- PPT $3.65
- Analyst Decision
- ALDX Strong Buy
- PPT
- Analyst Count
- ALDX 2
- PPT 0
- Target Price
- ALDX $9.50
- PPT N/A
- AVG Volume (30 Days)
- ALDX 917.6K
- PPT 156.1K
- Earning Date
- ALDX 08-07-2025
- PPT 01-01-0001
- Dividend Yield
- ALDX N/A
- PPT 8.84%
- EPS Growth
- ALDX N/A
- PPT N/A
- EPS
- ALDX N/A
- PPT N/A
- Revenue
- ALDX N/A
- PPT N/A
- Revenue This Year
- ALDX N/A
- PPT N/A
- Revenue Next Year
- ALDX $29.89
- PPT N/A
- P/E Ratio
- ALDX N/A
- PPT N/A
- Revenue Growth
- ALDX N/A
- PPT N/A
- 52 Week Low
- ALDX $1.14
- PPT $3.25
- 52 Week High
- ALDX $7.20
- PPT $3.72
- Technical
- Relative Strength Index (RSI)
- ALDX 71.16
- PPT 46.54
- Support Level
- ALDX $5.34
- PPT $3.64
- Resistance Level
- ALDX $5.73
- PPT $3.70
- Average True Range (ATR)
- ALDX 0.27
- PPT 0.02
- MACD
- ALDX 0.01
- PPT -0.00
- Stochastic Oscillator
- ALDX 77.36
- PPT 21.67
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About PPT Putnam Premier Income Trust
Putnam Premier Income Trust is a Massachusetts business trust operating as a non-diversified closed-end management investment company. The fund is currently operating as a diversified fund. Its investment objective is to seek high current income consistent with the preservation of capital by allocating its investments to the U.S. government sector.